CH BIOTECH SER
080370.5652.59% ( -0.015 )
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CH BIOTECH SER(08037) the Revenue is 18.61 M (+49.71%);the EBIT is -16 M (-139.2%);the EPS is 0.0093 (+157%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B49.71%
----
----
EBIT
-0.02B139.18%
----
----
EPS
0.0093156.95%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf